Contribution of genetic background and antiretroviral therapy to body fat changes in antiretroviral-naive HIV-infected adults

被引:9
作者
Egana-Gorrono, L. [1 ]
Martinez, E. [2 ]
Perez, I. [2 ]
Escriba, T. [1 ]
Domingo, P. [3 ]
Gatell, J. M. [1 ,2 ]
Arnedo, M. [1 ]
机构
[1] IDIBAPS, Retrovirol & Viral Immunopathol Lab, Grp Genom & Pharmacogen, Barcelona, Spain
[2] Univ Barcelona, Hosp Clin Barcelona, Dept Infect Dis, Barcelona, Spain
[3] Hosp Santa Creu & Sant Pau, Dept Infect Dis, Barcelona, Spain
关键词
host genetics; ART; IRS1; LDLR; APOE; SINGLE-NUCLEOTIDE POLYMORPHISMS; CORONARY-ARTERY-DISEASE; INSULIN-RESISTANCE; RISK-FACTORS; CARDIOVASCULAR RISK; CANDIDATE GENES; LIPID-LEVELS; LIPODYSTROPHY; DYSLIPIDEMIA; GLUCOSE;
D O I
10.1093/jac/dku266
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
To evaluate the association of host genetics with changes in limb or trunk fat in a group of antiretroviral therapy (ART)-naive HIV-infected patients prospectively followed up according to the initiation and the type of ART. Fifty single nucleotide polymorphisms (SNPs) in 26 genes, associated with obesity, insulin resistance, lipid metabolism or lipodystrophy in previously published genetic studies, were assessed in ART-naive HIV-infected Caucasian patients divided into three groups: 24 (27%) did not start ART, 29 (32.6%) received zidovudine or stavudine and 36 (40.4%) received neither zidovudine nor stavudine in their initial regimen. Patients underwent body fat measurements (using dual-energy X-ray absorptiometry) at baseline and Month 12. A multivariate model using backward stepwise elimination was used to assess the influence of SNPs and baseline levels of non-genetic covariates on changes in limb or trunk fat. The baseline characteristics were: 73% men, 17% coinfected with hepatitis C virus and/or hepatitis B virus, median age 37 years, median CD4+ T cell count 228/mm(3), median HIV-RNA 5.2 log copies/mL, median plasma glucose 85 mg/dL, median plasma insulin 9.1 IU/mL, median limb fat 5.6 kg and median trunk fat 7.0 kg. There were no baseline differences among the three groups except for the CD4+ T cell count. The decrease in limb fat was greater in the no-ART group relative to the other two groups (PaEuroS < aEuroS0.05). The multivariate model showed associations of rs1801278 in IRS1 (PaEuroS=aEuroS0.029, ORaEuroS=aEuroS0.13), baseline viral load (PaEuroS=aEuroS0.006; ORaEuroS=aEuroS4.453) and baseline glucose levels (PaEuroS=aEuroS0.008, ORaEuroS=aEuroS0.926) with loss of limb fat, and rs2228671 in LDLR (PaEuroS=aEuroS0.012, ORaEuroS=aEuroS0.108), rs405509 in APOE (PaEuroS=aEuroS0.048, ORaEuroS=aEuroS0.205), baseline viral load (PaEuroS=aEuroS0.005, ORaEuroS=aEuroS0.186) and baseline CD4+ T cell count (PaEuroS=aEuroS0.01, ORaEuroS=aEuroS1.008) with gain of trunk fat. Specific polymorphisms in IRS1 (limb fat loss) and LDLR and APOE (trunk fat gain) were identified as independent markers of fat changes irrespective of the initiation of ART and the type of ART and deserve further validation.
引用
收藏
页码:3076 / 3084
页数:9
相关论文
共 53 条
  • [1] Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy
    Arnedo, Mireia
    Taffe, Patrick
    Sahli, Roland
    Furrer, Hansjakob
    Hirschel, Bernard
    Elzi, Luigia
    Weber, Rainer
    Vernazza, Pietro
    Bernasconi, Enos
    Darioli, Roger
    Bergmann, Sven
    Beckmann, Jacques S.
    Telenti, Amalio
    Tarr, Philip E.
    [J]. PHARMACOGENETICS AND GENOMICS, 2007, 17 (09) : 755 - 764
  • [2] IL-1β (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome
    Asensi, Victor
    Rego, Carolina
    Montes, A. Hugo
    Collazos, Julio
    Carton, Jos A.
    Castro, Monica G.
    Alvarez, Victoria
    Fernandez, Cristina
    Maradona, Jos A.
    Valle-Garay, Eulalla
    [J]. GENETICS IN MEDICINE, 2008, 10 (03) : 215 - 223
  • [3] Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts
    Aulchenko, Yurii S.
    Ripatti, Samuli
    Lindqvist, Ida
    Boomsma, Dorret
    Heid, Iris M.
    Pramstaller, Peter P.
    Penninx, Brenda W. J. H.
    Janssens, A. Cecile J. W.
    Wilson, James F.
    Spector, Tim
    Martin, Nicholas G.
    Pedersen, Nancy L.
    Kyvik, Kirsten Ohm
    Kaprio, Jaakko
    Hofman, Albert
    Freimer, Nelson B.
    Jarvelin, Marjo-Riitta
    Gyllensten, Ulf
    Campbell, Harry
    Rudan, Igor
    Johansson, Asa
    Marroni, Fabio
    Hayward, Caroline
    Vitart, Veronique
    Jonasson, Inger
    Pattaro, Cristian
    Wright, Alan
    Hastie, Nick
    Pichler, Irene
    Hicks, Andrew A.
    Falchi, Mario
    Willemsen, Gonneke
    Hottenga, Jouke-Jan
    de Geus, Eco J. C.
    Montgomery, Grant W.
    Whitfield, John
    Magnusson, Patrik
    Saharinen, Juha
    Perola, Markus
    Silander, Kaisa
    Isaacs, Aaron
    Sijbrands, Eric J. G.
    Uitterlinden, Andre G.
    Witteman, Jacqueline C. M.
    Oostra, Ben A.
    Elliott, Paul
    Ruokonen, Aimo
    Sabatti, Chiara
    Gieger, Christian
    Meitinger, Thomas
    [J]. NATURE GENETICS, 2009, 41 (01) : 47 - 55
  • [4] Bogner JR, 2001, J ACQ IMMUN DEF SYND, V27, P237, DOI 10.1097/00126334-200107010-00004
  • [5] Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment
    Capeau, Jacqueline
    Bouteloup, Vincent
    Katlama, Christine
    Bastard, Jean-Philippe
    Guiyedi, Vincent
    Salmon-Ceron, Dominique
    Protopopescu, Camelia
    Leport, Catherine
    Raffi, Francois
    Chene, Genevieve
    [J]. AIDS, 2012, 26 (03) : 303 - 314
  • [6] HIV-associated lipodystrophy: from fat injury to premature aging
    Caron-Debarle, Martine
    Lagathu, Claire
    Boccara, Franck
    Vigouroux, Corinne
    Capeau, Jacqueline
    [J]. TRENDS IN MOLECULAR MEDICINE, 2010, 16 (05) : 218 - 229
  • [7] A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
    Carr, A
    Samaras, K
    Burton, S
    Law, M
    Freund, J
    Chisholm, DJ
    Cooper, DA
    [J]. AIDS, 1998, 12 (07) : F51 - F58
  • [8] Replicating genotype-phenotype associations
    Chanock, Stephen J.
    Manolio, Teri
    Boehnke, Michael
    Boerwinkle, Eric
    Hunter, David J.
    Thomas, Gilles
    Hirschhorn, Joel N.
    Abecasis, Goncalo
    Altshuler, David
    Bailey-Wilson, Joan E.
    Brooks, Lisa D.
    Cardon, Lon R.
    Daly, Mark
    Donnelly, Peter
    Fraumeni, Joseph F., Jr.
    Freimer, Nelson B.
    Gerhard, Daniela S.
    Gunter, Chris
    Guttmacher, Alan E.
    Guyer, Mark S.
    Harris, Emily L.
    Hoh, Josephine
    Hoover, Robert
    Kong, C. Augustine
    Merikangas, Kathleen R.
    Morton, Cynthia C.
    Palmer, Lyle J.
    Phimister, Elizabeth G.
    Rice, John P.
    Roberts, Jerry
    Rotimi, Charles
    Tucker, Margaret A.
    Vogan, Kyle J.
    Wacholder, Sholom
    Wijsman, Ellen M.
    Winn, Deborah M.
    Collins, Francis S.
    [J]. NATURE, 2007, 447 (7145) : 655 - 660
  • [9] Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy
    Egana-Gorrono, Lander
    Martinez, Esteban
    Cormand, Bru
    Escriba, Tuixent
    Gatell, Jose
    Arnedo, Mireia
    [J]. AIDS, 2013, 27 (04) : 529 - 538
  • [10] Enns JE, 2011, J OBES, V2011, DOI 10.1155/2011/168659